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The Risk of Deterioration in GCS13–15 Patients
with Traumatic Brain Injury Identified
by Computed Tomography Imaging:
A Systematic Review and Meta-Analysis
Carl Marincowitz,1 Fiona E. Lecky,2 William Townend,3
Aditya Borakati,4 Andrea Fabbri,5 and Trevor A. Sheldon6
Abstract
The optimal management of mild traumatic brain injury (TBI) patients with injuries identified by computed tomography
(CT) brain scan is unclear. Some guidelines recommend hospital admission for an observation period of at least 24 h.
Others argue that selected lower-risk patients can be discharged from the Emergency Department (ED). The objective of
our review and meta-analysis was to estimate the risk of death, neurosurgical intervention, and clinical deterioration in
mild TBI patients with injuries identified by CT brain scan, and assess which patient factors affect the risk of these
outcomes. A systematic review and meta-analysis adhering to PRISMA standards of protocol and reporting were con-
ducted. Study selection was performed by two independent reviewers. Meta-analysis using a random effects model was
undertaken to estimate pooled risks for: clinical deterioration, neurosurgical intervention, and death. Meta-regression was
used to explore between-study variation in outcome estimates using study population characteristics. Forty-nine primary
studies and five reviews were identified that met the inclusion criteria. The estimated pooled risk for the outcomes of
interest were: clinical deterioration 11.7% (95% confidence interval [CI]: 11.7%–15.8%), neurosurgical intervention 3.5%
(95% CI: 2.2%–4.9%), and death 1.4% (95% CI: 0.8%–2.2%). Twenty-one studies presented within-study estimates of the
effect of patient factors. Meta-regression of study characteristics and pooling of within-study estimates of risk factor effect
found the following factors significantly affected the risk for adverse outcomes: age, initial Glasgow Coma Scale (GCS),
type of injury, and anti-coagulation. The generalizability of many studies was limited due to population selection. Mild
TBI patients with injuries identified by CT brain scan have a small but clinically important risk for serious adverse
outcomes. This review has identified several prognostic factors; research is needed to derive and validate a usable clinical
decision rule so that low-risk patients can be safely discharged from the ED.
Keywords: intra-cranial hemorrhage; mild traumatic brain injury; minor head injury; prognostic modeling
Introduction
T
here are 1.4 million annual attendances in England and
Wales to Emergency Departments (EDs) following a head
injury (any trauma to the head), and in 2010, 2.5 million people
were treated for traumatic brain injury (TBI; injury to the brain or
alteration of brain function due to an external force) in the United
States.1 Approximately 95% of patients have an initial Glasgow
Coma Scale (GCS) of 13–15, out of a possible 15, indicating
normal or mildly impaired responsiveness and orientation.1,2 In this
large group with head injury and a high conscious level at pre-
sentation, research has focused on developing decision rules to
identify patients who require computed tomography (CT) imaging
due to their risk for life-threatening TBI.
In the United Kingdom (UK), National Institute for Health and
Care Excellence (NICE) and Scottish Intercollegiate Guidelines
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Network (SIGN)guidelines are used for this risk assessment, basedon
the Canadian CT head Rule (CCHR).1,3,4 Only 1% of head-injured
patients have life-threatening TBI.1,4 However, 7% have TBI iden-
tified by CT imaging.5
Most TBI patients who require neurosurgical intervention are
identified soon after presentation. The optimal management of the
remaining patients in this group remains controversial. A propor-
tion will deteriorate due to the progression of their injuries, and so
some studies advocate admission to higher dependency levels of
care and repeat CT imaging.6,7
Other studies report that some low-risk patients may be safely
discharged after a short period of observation in the ED.8,9 Perel
and colleagues have previously outlined how prognostic models
can aid clinical decision-making in TBI.10 Subsequent prognostic
models, including the IMPACT, TARN, and CRASHmodels, have
been useful in predicting adverse outcomes in patients with more
severe TBI, but they are not applicable to this patient group.11–13
Equivalent prognostic models for GCS13–15 patients with CT-
identified TBI may help safely reduce hospital admissions.
This review is the first to give an overview of the risk for adverse
outcomes and prognostic factors in patients with mild TBI (a high or
normal conscious level with traumatically induced brain dysfunction)
and injuries identified by CT brain scan. The review specifically:
(i) Estimates the overall risk for adverse outcomes in patients who
are initially GCS13–15 in the EDwhen TBI is identified by CT
imaging.
(ii) Assesses which prognostic factors affect the risk for deteriora-
tion and other clinically important outcomes in this population.
Methods
A systematic review was conducted using the PRISMA P protocol
and is reported in accordance with PRISMA guidelines.14 The review
is registered with the PROSPERO prospective register of systematic
reviews and (protocol is available at http://www.crd.york.ac.uk/
PROSPERO/display_record.asp?ID=CRD42016051585).
Inclusion criteria
Participants. Criteria were patients aged ‡12 years with an
initial GCS of 13–15 with TBI identified by CT imaging. TBI
included any traumatic extra-dural hemorrhage, subdural hemor-
rhage, intra-cerebral hemorrhage, subarachnoid hemorrhage, ce-
rebral contusion, or skull fracture. Studies had to be conducted in
the context of an emergency hospital attendance including a pre-
sentation to the ED or during admission to an inpatient ward.
Prognostic factors. Factors potentially affecting the risk for
adverse outcomes were included in the analysis if they were patient
factors present at admission including: demographic characteris-
tics, co-morbidities, medication use, symptoms, other clinical
features, or factors available from initial investigations.
Outcome measures. Primary outcomes were: death, neuro-
surgical intervention, or any other measure of clinical deterioration
such that admission to a hospital was warranted. Secondary out-
come was: progression of TBI on repeat CT imaging.
Types of study design. All studies, other than case studies,
were included.
Search methods for study identification
Studies published before 1996 were excluded due to more liberal
use of CT imaging to diagnose TBI after this date.5
The following electronic databases were searched with results
restricted to English language studies:
 EMBASE (via OVID) searched 11/24/2016: 1996 to 2016,
week 47;
 MEDLINE (R) (via OVID) searched 11/24/2016: 1996 to
November, week 3, 2016;
 CINHAL plus (via EBSCO) searched 11/24/2016: 1983 to
2016;
 Cochrane Central Register of Controlled Trials (CENTRAL);
The Cochrane Library,2016, all available dates. Accessed 11/
24/2016.
The full search strategy is reported in Supplementary Table 1 (see
online supplementary material at http://www.liebertpub.com).
The reference and citation searches of several national guidelines,
reports, and reviews included: NICE, SIGN, and Australian New
SouthWales (NSW)guidelines;National Institute forHealthResearch
(NIHR) Health TechnologyAssessment of management strategies for
minor head injury; the results of the World Health Organization
(WHO) collaboration on prognosis in mild TBI; systematic reviews
assessing prognostic factors in TBI; and systematic reviews assessing
the utility of repeat CT imaging in minor head injury.1,3,10,15–20 All
included studies’ references and citations were searched.
The Trauma Audit and Research Network (TARN)-listed pub-
lications were searched via the TARN website (https://www.tarn
.ac.uk/Content.aspx?ca=9&c=70; accessed 3/10/2017).
Data management and extraction
Identified studies were stored in EndNote X8 and duplicates
removed.
Study selection. Two reviewers (CM and AB) independently
completed title and abstract screening. Full reports of any studies
that potentially met the inclusion were selected and assessed. These
were screened, and studies that did not meet the inclusion criteria
were discarded with documented reasons. Disagreements were
resolved through discussion or arbitration by a third reviewer (TS).
Data extraction. The following data were extracted using a pre-
piloted data extraction tool: study population and demographics, sample
size, outcomes assessed, prognostic factors assessed, whether uni-
variable or multi-variable modeling had been undertaken, and the
overall results of the study. The selection criteria of studies were re-
corded to assesswhether sub-populationswith different risk profiles had
been studied.Thedata extracted are presented inSupplementaryTable 2
(see online supplementary material at http://www.liebertpub.com).
Assessment of the risk of bias. The Quality in Prognostic
Studies (QUIPS) tool was used to assess the quality of included
studies, particularly for the risk of bias.21 Six domains were assessed:
study participation, study attrition, prognostic factor measurement,
outcome measurement, study confounding, and statistical analysis
and reporting.
Statistical analysis
Three forms of analysis were undertaken: pooling of adverse out-
comes reported in studies, identification of risk factors by exploration
of between-study variation in outcomes by study characteristics, and a
synthesis of common risk factors assessed within studies.
A pooled prevalence of the adverse outcomes of interest and
confidence intervals for individual studies were estimated using the
Metaprop function (STATA-SE 14).22 The Freeman-Tukey double
arscine transformation was used to include studies with no adverse
outcomes, and a random effects model was used due to study het-
erogeneity.23
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Between-study heterogeneity estimates of outcomeswere explored
using subgroup analysis.Meta-regression of study characteristics was
used to identify factors that affected the risk for the outcomes of
interest. Meta-regression of multiple study characteristics’ effect on
the prevalence of adverse outcomes was assessed using the Metareg
function (STATA-SE 14) with weighting incorporating a measure of
between-study variation (tau2).24,25 The log odds of clinical deterio-
ration, neurosurgical intervention, and death were assessed as de-
pendent variables and the standard error of the log odds was used to
approximate the within-study standard error. To account for studies
with no outcomes, 0.5 was added to both the outcome estimates and
the sample size (consequently, in graphic representations of the meta-
regression the estimated risk can only tend toward zero).
Where studies had assessed the effect of risk factors on the
outcomes of interest using individual data, analysis was categorized
as uni-variable or multi-variable. Uni-variable meta-analysis of
prognostic factor effect estimates reported in primary studies was
completed using Review Manager 5.3 where possible.26 A random
effects model was used due to the heterogeneity of study popula-
tions, prognostic factor, and outcome measures.23Meta-analysis of
multi-variable models was not possible due to limited numbers and
variation in outcome and prognostic factor measurement.
Results
Search result
Theelectronic search strategywas completed onNovember 24,2016,
and identified 4665 studies. Of these, 412were duplicates, leaving 4253
studies for title and abstract screening (Fig. 1). Following title and
abstract screening, 69 studies6,9,27–93 and two reviews19,20 were
retrieved. A ‘‘gray’’ literature search identified a further 129 studies
for title and abstract screening, of which three were retrieved.94–96
Reference and citation searching of included studies and selected
reviews and guidelines identified another 46 studies7,8,39,97–139 for full
retrieval and three additional systematic reviews17,18,140 for reference
and citation searches.
In total, 118 primary studies and five systematic reviews were
retrieved.
Study selection. Forty-nine primary studies met the inclusion
criteria.6–9,27,28,30,32,37,41,42,52,54,55,57,59,60,62,63,65,66,69,71,73–78,86,87,90,93,
97–104,106–109,114,125,130,139 One review presented new study data.18The
four remaining reviews formed part of the narrative synthesis.17,19,20,140
The reasons for excluding the remaining 69 studies are presented in
Supplementary Table 3 (see online supplementary material at http://
www.liebertpub.com). Anonymized individual patient data were pro-
vided by the authors of a cohort study to allow outcomes for initial
GCS13-15 patients to be calculated, so this study is included.139
Study characteristics. Supplementary Table 4 presents the
characteristics of included studies (see online supplementarymaterial
at http://www.liebertpub.com). Seven prospective studies were
identified28,66,74,75,90,114,139 and four studies had a sample size of over
1000.63,87,98,108 Forty-six studies estimated the outcomes of interest
and contributed to pooled estimates of risk.6–9,27,28,30,32,37,41,42,52,
54,55,57,59,60,62,63,65,66,69,71,73–78,86,87,90,93,97–104,106–109,114,125,130,139
Four studies presented data regarding specific injury subtypes.32,55,71,103
FIG. 1. PRISMA flow-diagram showing selection of studies for inclusion in the systematic review.
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One study only contributed to the narrative synthesis due to the outcome
measure it assessed.42 Three studies presented the Brain Injury Guide-
lines (BIG) risk stratification tool.9,27,109 As this tool was applied to all
TBI patients and initial GCS forms part of risk stratification, these
studies contributed to the narrative synthesis.
Twenty-one studies presented either uni-variate or multi-
variable analysis assessing prognostic factors’ effect on the out-
comes of interest.6,37,41,54,55,66,69,71,73–78,87,98–101,130,139 Sixteen
studies presented multi-variable models using logistic regression or
recursive partitioning.6,37,41,54,55,66,69,71,73,74,77,78,98,100,101,130 Only
two studies attempted to validate such models by splitting the study
datasets.66,98
Quality assessment. QUIPS quality scores are presented in
Supplementary Table 2.21 The following common methodological
issues were identified.
Study recruitment was often not representative of all GCS 13–15
patients with TBI identified by CT imaging. Sixteen studies that
contributed to the pooled estimates of adverse outcomes only included
patients who had undergone repeat CT imaging, and so are likely to
represent a higher-risk population.7,18,54,74–78,86,90,102,104,106,107,125,130
Even when re-imaging was presented as routine practice, it was often
indicated that not all patients were re-imaged and included in analy-
sis.6Many other studies excluded higher-risk anti-coagulated patients
or those with more severe injuries.
Prognostic factor measurement was not consistent. Continuous
variables were dichotomized at different thresholds or the same risk
factor was measured with different methods. For example, the se-
verity of injury identified by CT imaging was assessed with 10 dif-
ferent measures. Most studies were retrospective and reliant on the
accuracy of case notes and radiological reports. The small sample size
of many studies prevented multi-variable modeling with all variables
identified in uni-variable modeling as affecting deterioration.37
In 32 studies, outcomes were assessed during inpatient admis-
sion, and so patients who were discharged and deteriorated were
missed. In other studies, is wasn’t clear when outcome measures
were assessed. Eight different measures of clinical deterioration
were used in 18 studies.
Several studies included patients with extra-cranial injuries and
significant co-morbidities. Extra-cranial injuries caused clinical
interventions, and in studies that measured deterioration in this
way this was a potential source of bias.66 Other studies indicated
some recorded deaths were related to co-morbidities instead of
TBI.41,73
Risk of adverse outcomes and exploration
of between-study variation
Death. Twenty-seven studies assessed the outcome of
death.6,8,28,41,52,57,60,62,63,65,69,73–75,78,86,93,97,99–102,104,114,125,130,139
The estimated risk of death for these studies ranged between 0–6%
(median 1.1%), andwith a pooled prevalence of 1.4% (95% confidence
interval [CI]: 0.8%–2.2%; Fig. 2). Studies that selected only initial
GCS15 patients had a pooled estimate of mortality of 0.03% (95% CI:
0%–0.28%). Studies that selected populations for non-intensive
care unit (non-ICU) admission or other conservative care pathways
had an estimated prevalence of death of 0.1% (95% CI: 0%–0.6%).
The effect on mortality of mean GCS, average age, and selection
of study population for a lower level of care was explored using
meta-regression. Increased age of study population was associated
with a higher risk for death (1.05, 95% CI: 1.00–1.12; Fig. 3),
whereas higher study population GCS was associated with a lower
risk for death (0.12, 95% CI: 0.02–0.86; Fig. 4). The percentage
of patients taking anti-coagulants in studies was not associated
with the prevalence of death (1.05, 95% CI: 0.95–1.17), but se-
lection for a lower level of care compared with a higher level of
care was (0.27, 95C.I: 0.08–0.94). When average age of the study
population and mean study GCS were assessed in a multi-variable
model they remained statistically significant predictors of mortal-
ity (Table 1), with an adjusted R squared of 38%, indicating that
these two factors explained over one-third of the variation in study
estimates.
Neurosurgical intervention. Thirty-six studies reported neuro-
surgical outcomes.6–9,27,30,37,52,54,57,60,62,63,65,66,73–78,86,90,93,97–102,104,106,
109,114,125,130,139 Figure 5 presents the estimates of the proportion of
patients who underwent a neurosurgical procedure stratified by the
GCS inclusion criteria. Reported neurosurgical intervention prev-
alence ranged between 0 and 26% (median 3.1%). The high pro-
portion requiring neurosurgical intervention reported by Beynon
and associates93 may reflect the greater use of anti-coagulants or
anti-platelets (33/70 participants).
The pooled estimated neurosurgical intervention risk was 3.5%
(95% CI: 2.2%–4.9%). An I2 of 96.4% indicated considerable
heterogeneity. Studies conducted on initial GCS 15 patients had a
lower prevalence of neurosurgical intervention: 0.2% (95% CI:
0%–0.5%). Sensitivity analysis of selection of the study population
for reduced care, such as discharge, a non-ICU admission or non-
routine repeat CT imaging found the pooled estimate of neurosur-
gical intervention in these studies to be 0.1% (95% CI: 0%–0.5%).
The of result of meta-regression using: mean study population
GCS, mean study population age, anti-coagulation, and selection
of study population for non-ICU admission or other reduced care
pathways is shown in Figures 6–8 and Table 1. Increasing age
(1.01, 95% CI: 1.02–1.11) and increasing percentage of study
population taking anti-coagulants (1.1, 95% CI: 1.01–1.19) was
associated with a higher risk, whereas an increasing GCS (0.71,
95% CI:0.01–0.56) was associated with a lower risk, of neurosur-
gical intervention.
Figure 7 shows a cluster of four small studies with low mean
ages that appear to have a disproportionately low estimated prev-
alence of neurosurgical intervention.8,52,62,106 This is explained by:
exclusion of anti-coagulated patients,8,52,62 selection of patients for
non-ICU admission or other reduced other care pathays,8,52,62 and
exclusion of patients with large injuries.8
When the effect of population selection for reduced clinical
management, exclusion of anti-coagulated patients (only 23/36
studies reported percentage of anti-coagulated patients), mean age,
and GCS of the study population were all included in a meta-
regression, age and GCS were the only statistically significant
predictors of neurosurgical intervention (Table 1). The adjusted R
squared of the model was 48%, indicating that these factors ac-
counted for almost half of between-study variation.
Clinical deterioration. Eighteen studies measured prevalence
of clinical deterioration.8,37,41,63,66,69,73,74,76–78,100,101,104,107,108,114,125
The estimated risk of deterioration ranged between 0 and 24.5%
(median 12.8%). Figure 9 presents study estimates of the percentage
of patients who deteriorated, with 95% CIs and stratified by how
the outcome was assessed. A pooled prevalence of 11.7% (95% CI:
8.21%–5.8%) for some form of clinical deterioration was estimated
with an I2 of 95.7%.
Estimates were stratified by: initial GCS of patients, whether the
included population were all selected for repeat CT imaging, the
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inclusion of anti-coagulated patients, the follow-up period, and
exclusion of patients with extra-cranial injuries. None of these
factors reduced the observed between-study heterogeneity.
The effect of: mean GCS study population, mean age study
population, study population selection, exclusion of patients with
extra-cranial injuries, and exclusion of anti-coagulated patients was
explored using meta-regression. As only 18 studies measured this
outcome, the model was restricted to two variables. No factor as-
sessed individually or in conjunction with another factor was found
to statistically affect the risk of clinical deterioration. Higher age
FIG. 2. Risk for death stratified by initial Glasgow Coma Scale (GCS).
FIG. 3. Meta-regression of risk for death by mean age study
population (coefficient odds 1.05, 95% confidence interval [CI]:
1.00–1.12; p = 0.049).
FIG. 4. Meta-regression of risk for death by mean Glasgow
Coma Scale (GCS) study population (coefficient odds 0.12, 95%
confidence interval [CI]: 0.02–0.86; p = 0.04).
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and lower GCS were non-statistically associated with a higher risk
of clinical deterioration (Table 1).
Progression on repeat CT imaging. Twenty-six studies
assessed the outcome progression of the initial injury on repeat
CT imaging.6,18,27,28,30,41,62,74–78,87,90,97,99–102,104,106–108,114,125,130
The prevalence of this outcome in these studies is presented in
Figure 10, stratified by whether studies only included patients who
had undergone repeat CT imaging. The pooled estimate for this
outcome was 15.6% (95% CI: 11.3%–20.4%). There is a high de-
gree of heterogeneity with a range in risk of progression between 2
and 48% (median 36.5%) and I2 = 97%. The non-statistically sig-
nificant higher pooled risk in studies that included only patients
who had undergone repeat CT imaging probably reflects selection
of higher-risk patients to repeat imaging. Subgroup analysis of
study characteristics did not find any factors that accounted for the
heterogeneity. This is probably the result of different criteria used
to triage patients to repeat CT imaging and definition of progression
of injury.
Prognostic factors assessed in primary studies
Twenty-one studies presented within-study estimates of effect of
individual risk factors on the outcomes of interest (Supplementary
Table 4) and the factors assessed are presented in Supplementary
Table 5 (see online supplementary material at http://www.liebertpub.
com).6,37,41,54,55,66,69,71,73–78,87,98–101,130,139 The most influential fac-
tors were: age, initial GCS, severity of CT finding, type of injury, anti-
coagulation, and anti-platelet medication (Table 2). Individual forest
plots are presented in Supplementary Table 6.
Age. Age was evaluated as a factor in prognostic modeling
in 18 primary studies.6,37,41,54,55,66,69,71,73,74,76–78,98–101,130 Ten
studies37,41,54,66,73,74,76–78,101 assessed age using four different di-
chotomous cutoffs and 11 studies measured age as a continuous
factor.6,55,69,71,73,76,77,98–100,130 Multi-variable models included: lo-
gistic regression with age either a dichotomized or continuous vari-
able, or decision tree analysis.
Of these 18 studies: six assessed the outcome of clinical dete-
rioration, eight assessed the outcome of neurosurgical intervention,
one measured death as an outcome, and eight studies evaluated
progression of injury on repeat CT imaging. Despite being the most
commonly assessed prognostic factor, due to the variation in mea-
surement and the outcomes assessed, it was not possible to undertake
a pooled analysis.
Increased age was associated with an adverse outcome in 9 of the
19 uni-variable models presented. Age was a significant predictor
of an adverse outcome in 2 of 5 multi-variable models where it was
treated as a continuous variable.69,71,98,130However, in 4 of 6multi-
variable models where it was dichotomized, older age predicted the
outcomes of interest.41,54,66,73,78,101 This may indicate a non-linear
relationship with older age groups having a disproportionately
higher associated risk for adverse outcomes.
Initial GCS. Twelve primary studies presented within-study
estimates of the effect of initial GCS on the risk of the outcomes of
interest.6,37,41,55,66,69,73,74,77,98,100,101 Uni-variable effect estimates
of initial GCS of 15 were pooled for studies assessing clinical
deterioration and neurosurgical intervention as an outcome with
individual patient data provided by Fabbri and co-workers, and an
initial GCS of 15 was protective against clinical deterioration or
neurosurgical intervention (pooled odds ratio [OR] 0.35, 95% CI:
0.23–0.53; Table 2).37,41,66,73,74,77,101 Two articles assessed pro-
gression of injury on repeat CT imaging and both found an initial
GCS of 15 to be associated with reduced risk of progression.74,77
Four studies estimated the effect of an initial GCS of 15 in multi-
variable models.37,66,73,101 All four multi-variable models found
Table 1. Meta-regression of Study Factors Predictive for Death, Neurosurgery, and Clinical Deterioration
Factor Outcome
Unit increase affect
odds uni-variable model
Unit increase affect
odds multi-variable model
Mean age study population Death 1.05 (95% CI: 1.0003–1.12), p= 0.049 1.06 (95% CI: 1.0002–1.12), p = 0.049
Mean GCS study population Death 0.12 (95% CI: 0.02–0.86), p = 0.04 0.09 (95% CI: 0.01–0.59), p= 0.02
Lower-risk study population
vs. ICU population
Death 0.27 (95% CI: 0.08–0.94), p = 0.04
Unselected study population
vs. ICU population
Death 0.81 (95% CI: 0.22–1.97), p = 0.63
Percentage population
anti-coagulated
Death 1.05 (95% CI: 0.95–1.17), p = 0.32
Mean age study population Neurosurgery 1.01 (95% CI: 1.02–1.11), p = 0.01 1.09 (95% CI: 1.02–1.16), p= 0.02
Mean GCS study population Neurosurgery 0.71 (95% CI: 0.01–0.56), p = 0.01 0.12 (95% CI: 0.02–0.91), p= 0.04
Lower-risk study population
vs. ICU population
Neurosurgery 0.13 (95% CI: 0.04–0.41), p < 0.01 0.67 (95% CI: 0.10–4.37), p= 0.66
Unselected study population
vs. ICU population
Neurosurgery 0.95 (95% CI: 0.43–2.12), p = 0.90 1.34 (95% CI: 0.45–4.02), p= 0.58
Percentage population
anti-coagulated
Neurosurgery 1.1 (95% CI: 1.01–1.19), p = 0.04
Exclusion of anti-coagulated
patients in study selection
Neurosurgery 0.63 (95% CI: 0.27–1.43), p = 0.26 1.33 (95% CI: 0.51–3.49), p= 0.54
Mean age study population Clinical
deterioration
1.01 (95% CI: 0.95–1.09), p = 0.64 1.02 (95% CI: 0.93–1.12), p= 0.59
Mean GCS study population Clinical
deterioration
0.36 (95% CI: 0.04–3.20), p = 0.33 0.26 (95% CI: 0.02–3.76), p= 0.29
CI, confidence interval; ICU, intensive care unit; GCS, Glasgow Coma Scale.
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initial GCS of 15 to be associated with a reduced risk of adverse
outcomes.
Severity of injury as assessed by CT findings. Nine
studies estimated whether the severity of injury identified by initial
CT scan predicted adverse outcomes.6,41,54,55,66,73,76,78,100This was
assessed by: the presence of midline shift or mass effect in five
studies,6,55,66,76,100 the Marshall classification in two studies,41,73
and measures of hemorrhage thickness or volume in four stud-
ies.54,55,78,100 The variability in the measures of injury severity and
differences in the outcomes assessed prevented pooling.
All studies that assessed presence of midline shift/mass effect
found it to be statistically predictive of adverse outcomes. This
association remained in the two studies that presented multi-
variable analysis.6,66 The Marshall classification was assessed as a
continuous73 and dichotomized variable,41 and neither study found
a statistically significant association with adverse outcomes.
The two studies that assessed the effect of bleed thickness
>10mm found this to be statistically predictive of either progres-
sion of injury on repeat CT imaging or neurosurgical intervention in
both uni- and multi-variable analysis.54,78
FIG. 5. Risk for neurosurgery stratified by the initial Glasgow Coma Scale (GCS) of the study population.
FIG. 6. Meta-regression of risk for neurosurgery by mean
Glasgow Coma Scale (GCS) study population (coefficient odds
0.71, 95% confidence interval [CI]: 0.01–0.56; p= 0.01).
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Isolated subarachnoid hemorrhage. Twelve studies pre-
sented outcomes for populations with isolated injuries and patients with
isolated subarachnoid hemorrhages (iSAH) had the lowest risk for ad-
verse outcomes: neurosurgical intervention pooled risk 0.01% (95%CI:
0%–0.7%;Fig. 11), and1.1% (95%CI: 0%–5.5%)pooledprevalenceof
clinical deterioration (Supplementary Fig. 1; (see online supplementary
material at http://www.liebertpub.com).32,37,55,59,71,74,77,98,99,103,107,108
Uni-variable effect estimates presented in the two studies that
assessed the effect of the presence of iSAH were pooled with data
extracted from three additional studies.37,73,77,98,108 The pooled
estimate indicated iSAH reduced the risk of neurosurgical inter-
vention/clinical deterioration (Table 2).
Two multi-variable models included iSAH as a prognostic fac-
tor. One found iSAH to be associated with a lower risk for clinical
deterioration.37 The other found iSAH to have no effect on risk.98
Isolated extra-dural hemorrhage. Patients with isolated
extra-dural hemorrhage had the highest risk for neurosurgical in-
tervention: 13.7% (95% CI: 9.3%–18.5%; Fig. 11); 18.5% is esti-
mated from a population of all initial GCS14–15 patients with
extra-dural hemorrhage, whereas the estimates in the other studies
are from populations that have been selected for more conservative
management.77,98,107,108
Three studies assessed isolated extra-dural hmorrhage as a
prognostic factor.37,73,98 A pooled risk estimate for clinical deteri-
oration or neurosurgical intervention using these three studies and
outcome data extracted from a further two studies,77,108 found iso-
lated extra-dural hemorrhage to be associated with these outcomes
(OR 2.26, 95% CI: 1.9–2.68; Table 2). Isolated extra-dural hem-
orrhage remained statistically associated with neurosurgical out-
comes in the only multi-variable model that included this factor.98
Anti-coagulation. Twelve studies estimated the prognostic ef-
fect of anti-coagulation.6,37,41,55,74,76–78,98,100,101,139 Measures of anti-
coagulation included: any documented coagulopathy,6,41,55,77,98,100
pre-injury warfarin use,37,76,101 warfarin or anti-platelet therapy as a
combined risk factor,78,100 and continuous laboratorymeasures of anti-
coagulation.6,74,101
Uni-variable effect estimates of dichotomous measures of anti-
coagulation were pooled with individual patient data from Fabbri
and colleagues for the composite outcome of clinical deterioration
or neurosurgical intervention (Table 2), pooled estimate: OR 1.45,
95% CI: 1.28–1.64.
Two studies presented multi-variable models that included anti-
coagulation and it was not statistically associated with the out-
comes of interest in either model.78,98
Anti-platelet medication. The effect of anti-platelet use was
evaluated by: aspirin use,37,76,101 clopidogrel use,37,76,101 and a
joint measure of anti-platelet use.55,66,87 No multi-variable models
included anti-platelet use. Pooled uni-variable risk estimates of pre-
injury aspirin and clopidogrel use are presented in Table 2. Meta-
analysis indicated a statistical association between clopidogrel and
clinical deterioration or neurosurgical intervention, but there was
no association between aspirin use and this outcome.
Discussion
Summary
We have completed a thorough systematic review and meta-
analysis to identify risk factors for adverse outcomes in this TBI
population. This is the first review to provide pooled estimates of
clinically important outcomes in this population and identify which
factors affect the risk for these outcomes.
The pooled prevalence for adverse outcomes was: 11.7% (95%CI:
8.21%–5.8%) clinical deterioration, 3.5% (95% CI: 2.2%–4.9%)
neurosurgical intervention, and 1.4% (95% CI: 0.8%–2.2%) death.
These outcome estimates used a pooled total of 65,724 patients and
are comparable to the 2.7% craniotomy rate reported for a similar
population in a national UK trauma database.94 The variation in in-
dividual study outcomes reflects differences in populations studied
and outcome definitions. For the outcomes of neurosurgical inter-
vention and death, heterogeneity could be explained by the age of
study populations and different study population GCS scores.
Risk factors for adverse outcomes were identified using both meta-
regression of study characteristics and synthesis of prognostic models
presented by primary studies. Age, anti-coagulation, and initial GCS
were found by both methods to affect risk. An increase in mean study
population age by one year was associated with increased odds of
neurosurgical intervention of 1.09 in multi-variable meta-regression
FIG. 8. Meta-regression of risk for neurosurgery by percentage
of study population taking anti-coagulants (coefficient odds 1.1,
95% confidence interval [CI]: 1.01–1.19; p = 0.04).
FIG. 7. Meta-regression of risk for neurosurgery by mean age
study population (coefficient odds 1.01, 95% confidence interval
[CI]: 1.02–1.11; p= 0.01).
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(Table 1), and age was a predictor for an adverse outcome in 6 of 11
multi-variable models presented in primary studies. In uni-variable
meta-regression a unit increase in the percentage of the study popu-
lation taking anti-coagulants was associated with a 1.1 increase in the
odds of neurosurgical intervention (Table 1). Pooling of uni-variable
models presented in primary studies found anti-coagulated patients to
have odds 1.45 times greater than patients not anti-coagulated for
neurosurgical intervention/clinical deterioration (Table 2). In multi-
variable meta-regression, a unit increase in mean/median study pop-
ulation GCS was associated with a 0.12 reduction in the odds of
neurosurgical intervention (Table 1). Pooling of uni-variable models
indicated that patients with an initial GCS <15 had odds of clinical
deterioration/neurosurgical intervention 2.9 times that of patients who
presented with an initial GCS of 15 (Table 2). In multi-variable meta-
regressionmodels including both initial GCS and age, initial GCS had
a smaller effect on the risk for either neurosurgical intervention or
death than in uni-variable analysis, and this may be due to older
patients presenting with higher initial GCS relative to the severity of
their injury (Table 1).141 Patients with extra-dural hemorrhage had the
highest prevalence of adverse outcomes, whereas patients with iSAH
had the lowest (Fig. 11).
Meta-analysis of multi-variable models was not possible due to
the small number and variability in how these models were con-
structed. Therefore, although this review has identified the factors
that affect risk, no model that could identify low-risk patients was
found or could be reliably constructed.
Strengths
A thorough search has been conducted, identifying 50 relevant pri-
mary studies. Our review fulfills all the AMSTAR systematic review
checklist quality domains apart from items 10 and 11, regarding the
assessment of publication bias and conflicts of interest.142However, the
non-interventional nature of the included studies means these domains
are less relevant. This review is low-risk for bias in the five domains
assessed by the Risk of Bias in Systematic reviews (ROBIS) tool.143
Limitations
Many studies identified were small and retrospective with limited
follow-up of patients after discharge. Instead of attempting to identify
low-risk patients through prognostic modeling, several studies se-
lected patients on study-specific characteristics for different care
pathways. This variation in study populations contributed to hetero-
geneity in estimates of outcome prevalence and risk-factor effect. The
prognostic models that were identified were often derived in cohorts
too small to construct multi-variable models with all relevant factors.
The clinically useful outcome in informing discharge decisions is
clinical deterioration, and most prognostic models did not assess this.
FIG. 9. Estimates of clinical deterioration stratified by the outcome measure.
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FIG. 10. Risk on repeat computed tomography (CT) imaging for progression of injury stratified by whether entire population selected
for repeat imaging.
Table 2. Summary of Effect Estimates of Risk Factors Assessed within Studies
Risk factor Number of studies assessed in Pooled uni-variable effecta
Effect
multi-variable
modelsb
Likely effect
on risk
Age 186,37,41,54,55,66,69,71,73,74,76–78,98–101,130 +6/11 1
Initial GCS 15 737,41,66,73,74,77,101 OR 0.35, 95% CI: 0.23–0.52 -4/4 2
Severity CT brain 96,41,54,55,66,73,76,78,100 +7/8 1
Isolated SAH 537,73,77,98,108 OR 0.19, 95% CI: 0.07–0.5 -1/2 2
Isolated EDH 537,73,77,98,108 OR 2.26, 95% CI: 1.9–2.68 +1/1 1
Isolated SDH 537,73,77,98,108 OR 1.82, 95% CI: 0.69–4.77 +2/2
Isolated contusion 337,98,108 OR 0.24, 95% CI: 0.2–0.28 0/1
Anti-coagulation 126,37,41,55,74,76–78,98,100,101,139 OR 1.45, 95% CI: 1.28–1.64 0/2 1
Aspirin 637,55,66,76,87,101 OR 1.30, 95% CI: 0.95–1.78
Clopidogrel 637,55,66,76,87,101 OR 1.79, 95% CI: 1.17–2.72 1
aPooled estimate of effect on risk of neurosurgery or clinical deterioration.
bIndicates number of multi-variable models where factor was found to be a significant predictor and direction of effect on risk.
CI, confidence interval; CT, computed tomography; EDH, extra-dural hemorrhage; GCS, Glasgow Coma Scale; OR, odds ratio; SAH, subarachnoid
hemorrhage.
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Clinical deterioration was defined by seven different composite
outcomes and most commonly by neurological deterioration. This
lack of consistency in definition contributed to the heterogeneity in
outcome estimates. Neurological deterioration was variably de-
fined and a clinically relevant and consistently used definition or
deterioration is required.
No included studies assessed pupillary response and duration of
loss of consciousness/amnesia. These factors are predictive for
adverse outcomes in other TBI populations and future research
should assess these factors in this population.13,144
Context
When the Canadian CT Head Rule was developed, the authors
presented a consensus-derived list of intra-cranial injuries that
would never require neurosurgical intervention.4 The implication
was that patients with such injuries were safe for discharge. This
was rejected by the Society of British Neurological Surgeons.1 A
U.S. group based in Arizona has produced the BIG consensus-
derived statement that identifies a population with low-risk clinical
characteristics and intra-cranial injuries similar to those presented
by the CCHR authors.109 They propose such patients are safe for
discharge after 6 h of ED observation.9,27,109
Kreitzer and associates present an alternative policy at a
level 1 trauma center in Cincinnati, where the population of
interest remains in the ED for observation and undergoes repeat
CT imaging approximately 6 h following diagnosis.86 Neuro-
logically stable patients without progression of injury are dis-
charged. Pruitt and co-workers present a model of care in a level
1 trauma center in Chicago in which all GCS13–15 patients
with intra-cranial injuries receive a neurosurgical consulta-
tion.108 Low-risk patients identified by the neurosurgeon are left
under ED care and discharged after a period of observation. This
is similar to the standard of care in the UK National Health Ser-
vice (NHS).
Others advocate the admission of GCS13–15 patients with brain
injuries identified by CT imaging to higher levels of care and
routine re-imaging, citing evidence that deterioration in neurolog-
ical examination may not identify progression of injury that war-
rants clinical intervention.6,78Multiple reviews have found that this
is too rare an occurrence to warrant routine re-imaging of all
GCS13–15 patients with TBI identified by CT.17–20
FIG. 11. Pooled risk for neurosurgery stratified by isolated injury type identified by initial computed tomography (CT) imaging.
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Implications
This review supports the view that there are subsets of
GCS13–15 patients with injuries identified by CT imaging who
may possibly be safely routinely discharged from the ED. How-
ever, the current available evidence is insufficient to reliably iden-
tify such low-risk patients. The risks for serious adverse outcomes
are sufficiently high that, in the absence of evidence to be able
to accurately pinpoint low-risk individual patients, admission for
observation probably remains clinically indicated.
No validated model predicting a measure of clinical deteriora-
tion that could be used to triage hospital admission was identified.
We suggest future research should assess a measure of clinical
deterioration that encompasses: neurosurgical intervention, death,
a fall in GCS by 2 or more points, seizure activity, intravenous
medical intervention, or ICU intervention. These would warrant
ongoing inpatient hospital admission.
TheBIGcriteria, although thebest effort at risk stratifying this group
in a clinically relevant way, require validation in larger prospective
cohorts in different health care contexts before being more widely
adopted. They were derived by consensus, and empirical prognostic
modeling could possibly improve the accuracy of risk stratification.
Decision rules have been employed successfully in the ED to
risk-stratify patients in a range of conditions, including ankle in-
juries and suspected pulmonary embolus.145,146 Equivalent models
could be used for patients with mild TBI to identify low-risk pa-
tients. This review has identified the key factors that are likely to
inform such risk stratification, but an adequately powered deriva-
tion study with a clinically relevant definition of deterioration and
adequate follow-up is required.
Conclusion
Mild TBI patients with injuries identified by CT imaging are a
heterogenous group. Their overall risk for clinical deterioration and
more serious adverse outcomes is small, but clinically significant.
Current research gives an indication to which factors affect the risk
for adverse outcomes but is of too low quality to inform clinical
decision-making. High-quality prognostic modeling is needed to
help inform discharge decisions.
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